Published 07:56 IST, March 12th 2024
NYCB finalises $1 billion capital infusion deal, announces reverse stock split
Following these developments, NYCB experienced a 5.8% surge in its share price during extended trading on Monday, reaching $3.44.
![NYCB capital infusion](https://img.republicworld.com/tr:w-800,h-450,q-75,f-auto/rimages/fotojet-2024-03-12t075521.776-171021035309116_9.webp)
NYCB capital infusion | Image:
Wikimedia Commons
- Listen to this article
- 2 min read
Advertisement
07:56 IST, March 12th 2024